Newstral
Article
Bbarrons.com on 2021-01-13 14:56
Regeneron Inks Deal to Sell Covid-19 Treatment to U.S., Even as Usage Lags
Related news
- BRegeneron Could Start a Covid-19 Treatment Test This Summerbarrons.com
- FDA approves first treatment for Ebola, a Regeneron antibody cocktailArs Technica
- Biotech firm Regeneron starts trials for coronavirus antibody treatmenttimesofisrael.com
- Regeneron facing patent infringement suit over Covid-19 treatmentwestfaironline.com
- BRegeneron Earnings Crushed Estimatesbarrons.com
- As teen vaping soars, treatment for nicotine addiction lagspressherald.com
- BRegeneron Data Shows Role for Antibody Treatment in Far Sicker Patients2 min readbarrons.com
- Eli Lilly, Regeneron, Gilead: What The Vaccine Means For Covid-19 Treatment StocksForbes
- Pfizer, Merck, Regeneron: Covid Treatment Stocks Back In Focus As Infections SoarForbes
- BRegeneron Says Covid-19 Treatment Might Not Work as Well Against Omicron1 min readbarrons.com
- Trump’s Regeneron COVID-19 treatment tested using aborted fetal tissue cellsNew York Post
- MRegeneron earnings beat expectations, plans to begin human studies of COVID-19 treatment in Junemarketwatch.com
- Regeneron COVID-19 treatment used by Trump to be shipped out starting TuesdayNew York Post
- BRegeneron Stock Climbs as Earnings Come in Strongbarrons.com
- Toledo lags in broadband usageThe Toledo Blade
- BRegeneron Jumps After Earnings Beat Expectationsbarrons.com
- BA Case to Buy Regeneron Stock After Its Recent Tumblebarrons.com
- BFDA Authorizes Lower Regeneron Covid-19 Antibody Dose. That Opens the Door to Bigger Sales.barrons.com
- BRegeneron Pharmaceuticals Reports Earnings Tomorrow. Here’s What to Expect.barrons.com
- BDexamethasone, remdesivir, Regeneron: Trump covid's treatment explainedbbc.co.uk